Apr
3

Sorry about that…

well, not really.

I’m referring to yesterday’s annual April Fool’s Day post, in which I “reported” Obamacare would include a single-payer federal workers’ comp system for small employers.  While some chalk it up to my sophomoric attempt at humor, (and they would be right), there’s another, more important takeaway, one that is particularly relevant in the work comp industry.

There’s a lot of mis-information out there, much in the form of reports, statistics, metrics, findings, research, and it often goes unchallenged.  Here are a couple examples.

“Research” published by benefits giant AFLAC claims companies that set up voluntary disability programs saw reductions in work comp claims.  Except the “research” is not credible, isn’t reproducible, is based on nothing more than opinion, and therefore is just marketing BS. (hat tip to Mark Larsen of WorkCompCentral for the info)

The key here is don’t believe “research” unless it is credible, which means there was a solid methodology (asking people their opinion then drawing a statistical conclusion from those opinions is NOT a solid methodology).

Vendor claims that they can “save” X% more than your current vendor on pharmacy/medical bills/provider costs/whatever are often – but not always – pure speculation.  Fact is, unless the vendor making the claim really, really understands what your current program/vendor is doing, how they are doing it, the methodology they are using to calculate results, and reviews the bill/provider/script data, their claims are suspect at best.

That’s not to say that some programs don’t deliver measurably better performance, but unless the vendor pitching you can provide a detailed analysis of why and how they can do better, they’re just blowing smoke.  How can you figure this out?  Simple – ask lots of questions – starting with how, when, who, how much, where.  Dig deep and do not be satisfied with generic marketing-speak answers.

You will find some vendors are only too happy to get into the details, while others get really uncomfortable.  And that tells you a lot about their REAL ability to deliver.

Finally, the April Fool’s post caught more than a few readers, so if you were one, you’re in pretty good company (there were several clients and a few regulators – all shall remain nameless – who fell for it).

What does this mean for you?

Don’t be an April – or any other month – fool.

 


Apr
1

Obamacare exchanges to be used for work comp enrollment

Turns out one reason the small employer mandate has been delayed is the Feds are incorporating a national “single payer” work comp program that is not quite ready for prime time.

The POWER (Protecting Our Workers and Ensuring Reemployment) program, which will be administered by the Office of Workers’ Compensation Programs, had been back-burnered while the tech folks worked on the other parts of the site, added capacity, and straightened out the back-end issues related to enrollment, payment, and citizen verification. POWER was not part of the original healthcare reform bill; it was initiated as part of a Presidential directive shortly after PPACA was passed and signed in to law.

Now that the health exchange “glitches” are mostly fixed, the expectation is the workers’ comp program will be moving very quickly. It should be much less complicated, as there will be a single payer (the Feds’ OWCP), a single payment system, and universal benefits and coverage specs.  Detailed in the POWER initiative, the program will measure employers’ performance across eight metrics, with those employers failing to demonstrate improvement targeted for additional Federal oversight.

DOL is targeting June 1 as the implementation date; small employers (26-99 employees) will be required to sign up for POWER as their current workers’ comp policies expire.  (The POWER press release says this should make for an “orderly and straightforward transition”; safe to say that’s highly doubtful).  Evidently employers WILL be allowed to “opt out” of POWER; this requires completion of an application of exemption, documentation of three years’ ex mods below 1.00, and a commitment from their current carrier to maintain current premiums; it has to be renewed every year.  While not too onerous, the paperwork and reporting burden may well give employers pause.

According to an OWCP press release, the POWER program is intended to “reduce the administrative burden on small employers while ensuring rapid, professional, and fair adjudication of claims for injured workers.”  Although this will “negatively impact” some insurance companies, the (anticipated) reduced expense for employers coupled with the additional oversight by OWCP staff will help “improve the competitiveness of America’s small business.”  POWER will use the OSHA reporting system to cross-index claims reporting to ensure all claims are captured; evidently there’s sensitivity/concern that some employers will avoid reporting claims to reduce the risk of the dreaded “additional Federal oversight.”

The details – The federal fee schedule will likely be used for medical treatment, and indemnity benefits will be almost certainly be pegged to the existing DOL standards.  OSHA will have to revamp their reporting process, with much more emphasis on timeliness and additional data points captured; expect the Exchange website to be used for claims reporting.

What does this mean for you?

We can only hope it doesn’t take months to figure it out.


Mar
31

Compounding drugs – myth v reality

There’s a lot of nonsense circulating about the wonders of compounded medications, almost all of it promulgated by companies and people in the compounding industry.

What’s notable about all of their claims is the complete lack of scientific research supporting their claims that more people need compounds, that compounds work, are safe, and deliver better results than non-compounded medications.

Turns out the reason these advocates don’t cite research is – the research doesn’t support the use of compounds for more than a very few patients.

That’s the key takeaway from CompPharma’s just-released research paper; Compounding is Confounding Worker’s Compensation.  You can download it here.

Here are a few of the findings:

  • Compounds have not been proven to be more effective than commercially available, manufactured drugs that have been approved by the U.S. Food and Drug Administration (FDA) in similar classes. In fact, efficacy data in general are non-existent for the types of compounds seen in workers’ compensation claims.
  • Using compounds poses risks to patients
  • Compounds are often not medically necessary
  • Compounds are expensive

Despite reports of outrageous cost inflation, dozens of deaths due to faulty processes and poor quality control, and little progress in improving oversight, compounding continues to plague work comp.

What does this mean for you?

Time to develop and implement a policy for approving and reimbursing for compounds – one based on science, and not marketing nonsense.

Note – I am president of CompPharma, altho I had little to do with the actual research paper; credit for that goes to the pharmacists and government affairs people from CompPharma’s member PBMs.  They did a terrific job.


Mar
26

Another bomb drops on physician dispensers

Allstate Insurance filed suit against physician dispensing “technology” firms Infinite Strategic Innovations Inc (ISI) and Doctors Medical LLC earlier this week.  This is the second in what may be an-ongoing series of legal actions by the giant insurer, and comes on the heels of a settlement in their earlier suit against dispensing “technology company” Automated Healthcare Solutions.  

While the AHCS suit has been dismissed, I think we can assume Allstate made out quite well in the “dismissal”; Allstate doesn’t move unless they are very confident, and they come with overwhelming force.  Even the most arrogant, litigious, and downright nasty opponents are going to quail in the face of an Allstate lawsuit. While no one’s talking,   it is logical that Allstate would not have allowed the suit to be withdrawn unless they were pretty darn happy with the resolution.

My guess is Doctors Medical’s owner, Tom Mollick, is having a very bad week. And things are not going to get any better for Mollick et al.

From reading the complaint, Allstate is claiming ISI and DM received payments totaling $93,265 for PIP claims in Michigan, and has billed Allstate another $443,751 for other claims.  Allstate wants (most of) their money back, doesn’t want to have to pay most of the pending claims, and wants ISI and DM to agree to stop billing the insurer.

The key parts of the suit include:

  • request for declaration judgment
  • a statement that ISI and DM have no standing to bill as they are not medical providers
  • request for restitution for claims adjusting, administrative, and legal costs
  • assertion that ISI and DM operated “under the umbrella” of Rx Development Associates, Inc.  

There’s a lot more to this, but the net is this.  This is the second in what may well be a series of suits against physician dispensing companies; my guess is Allstate won big in their initial suit against AHCS, and is pursuing Mollick now, and will go after other dispensing companies as well.

As the AHCS suit was withdrawn, we don’t know what the resolution was – and never will.  And more’s the pity, because Allstate may well have solved its problem, but did nothing to address the problem for the rest of the industry.  That’s understandable as it isn’t their lawyers’ job to fix other insurers’ problems.

Nonetheless, it would be…helpful if the result of these legal actions was public knowledge – it would give pause to the other dispensers and their cronies, alert other insurers to the issue, and, over the long term, reduce Michigan auto insurance costs.

What does this mean for you?

Check your payment records, figure out how much you’re paying dispensers and their enablers, and do something about it.

 


Mar
19

Reality vs magical thinking

Too many workers’ comp execs are allowing their political viewpoints to cloud their business thinking. They can’t abide the notion of PPACA/Obamacare, and along with the majority party in the House of Repesentatives, want it repealed or blown up or completely emasculated.

This is magical thinking.

And magical thinking will not help those execs, or their companies, prepare for or deal with the implications of Obamacare.

Look, as an proud socially-liberal Democrat (as if that’s any new news to you, dear reader), I had to suffer thru 8 long, painful, miserable, agonizing, soul-destroying years of George Bush.  For those of you on the other side of the political spectrum, I feel your pain.  Really.  Even if the current resident of 1600 Pennsylvania Ave is pretty far from a liberal (sorry, had to slip that in!).

That said, it’s time to accept reality.

PPACA/Obamacare is the law of the land, it is not going to be repealed, substantially delayed, or emasculated. It is here, and it is going to stay.

Despise it you might (as I despise Medicare Part D and the Medicare Modernization Act of 2003, and the Iraq war) but accept it you must.  If you spend your work time focused on what you don’t like about health reform, you’re not spending your time thinking about reform’s implications for workers’ comp – how you can mitigate any problems, leverage any advantages, and monitor and measure ways reform affects your business.

What does this mean for you?

Those who do focus on the business implications are going to be better prepared, and therefore more likely to be successful, than those who dwell on uncontrollables.


Mar
18

North Dakota’s WSI – what? listen to the Medical Director? Hah!

WSI’s legal folks are going around their own Medical Director to outside, part-time, contract medical directors when they want a certain opinion.

Thanks to Tony, I learned of the dispute between the North Dakota state fund’s medical director and that august entity’s legal department early today (hat tip to WorkCompCentral’s Peter Mantius); it took me quite a bit longer to get the back story on this mess.

And it is a mess.

Here’s the issue.  When the claims and legal departments want a specific answer about a medical issue on certain claims they DON’T ask WSI’s Medical Director.  No, they send it to one of two outside reviewers and skip routing it to, or even involving their in-house, full-time, employed Medical Director.  By all accounts the Medical Director, a Dr Luis Vilella, is widely respected, known to be a “team player”, and interested in nothing more than ensuring the claimant gets the right medical treatment and the correct medical determination.

Evidently some claims and legal folks at WSI don’t like it when their view of a claim is inconsistent with that of Dr V, which is why they avoid involving the good doctor on specific claims.  This has been going on for some months, until finally Dr V sent a letter about the issue to WSI’s director, the famous ex-state-trooper-now-workers’comp-CEO Bryan Klipfel. (the letter was obtained by the local paper in a freedom of information request)

In part, Vilella’s letter read: “How can WSI impartially adjudicate a medical claim when its own Director of Legal Services, Attorney Green, disregards litigation support that WSI’s Medical Director offers on matters of disease and injury causation?”

It would be bad enough if this was only on one claim – but it most definitely isn’t.  In fact, sources indicate this has been happening for several years, including at least two incidents where WSI managers tried to alter his medical opinions.  In addition, Vilella is being marginalized within WSI; excluded from meetings focused on medical topics, prevented from meeting with Sedgwick’s on-site auditors; and pushed three levels down below Klipfel in the reporting structure.

So we have the Medical Director in a work comp insurer – and a relatively tiny one at that – who reports up to a guy who reports up to another guy who reports up to a third guy who THEN reports to the top guy.  In Klipfel’s defense, he recently decided to fix that really stupid reporting structure, and Dr V will be reporting directly to him.

That said, Klipfel knew legal and claims were marginalizing Dr V ever since former boss Sandy Blunt was run out of town on a rail.   With Sandy’s departure, it appears as if the legal geniuses at WSI decided they were not only brilliant legal minds, but they were more suited to make medical decisions than a medical doctor.

After all, why would a state experiencing an explosive growth in workers’ comp claims, many of them complex, difficult, and traumatic, ever want to have a medical director in a position of authority?  In actuality, the treatment of Vilella reflects something much more troubling than just a series of blatantly stupid decisions by claims and legal.

It is prima facie evidence of Klipfel’s – and the WSI Board’s – complete lack of understanding of the primary importance of medical in workers’ comp claims.  Medical drives well over half of direct claims costs, and heavily influences the indemnity portion.  Yet the acknowledged expert in medical was multiple levels below the CEO – who, by the way, had ZERO experience in work comp, or business for that matter, until he was appointed to the top job.

I don’t know Vilella, but I do know several other folks at WSI. The ones I know are good people, doing the best job they can in very trying circumstances.  They really truly want to help injured workers.

It is too bad they are being “led” by idiots.


Mar
13

WCRI – California’s Work Comp Medical Dispute Resolution

Alex Swedlow, a certified rock star in the world of work comp analytics, held forth on medical dispute resolution as it exists in California.

MDR covers conflicts around the cost, utilization, and “standard of care”, these are evaluated against regulations, guidelines, fee schedules, and refereed by a judge, peer review doc, or some panel of designated experts.

California bill SB 863’s impacts were addressed, and include the following:

  • 3 million liens processed over ten years, but the re-enactment of a fee to file liens in 2013 has cut lien filing fee by over 80%
  • 90% of 2011-2012 liens came from a ten-mile radius in LA – but only 25% of WC claims
  • change to reimbursement for ASCs dropped 28% after a 31% drop in the relevant fee schedule

Now on to the most fun part of 863 – the Independent Medical Review (IMR) “program”.  As Alex said, “boy has IMR been proven popular.”

Volume is 12x the expected volume and runs above 12,000 per MONTH.

Just under 50% of all medical management fees are from UR.

Among the cases that go to elevated UR, about 43% are for pharmacy, most for opioids and compound drugs.  A third of IMR decisions are also for pharmacy.  There’s a lot of misunderstanding about how many medical requests are handled internally vs done by an outside physician reviewer.

Just under 6 percent of all treatment requests were denied or modified before getting to IMR.  4.7% of all treatment requests are denied at the IMR stage.

Less than one in 20 treatment requests are ultimately denied via IMR.

75% approved internally, 18% are approved by elevated review; 4.7% are ultimately denied by the IMR process.

Less than one in 20 treatment requests are ultimately denied via IMR.

CWCI’s next step is to look into how a pharmacy formulary would affect pharmacy spend and scripts; looks like it would dramatically reduce the use of opioids, brand drugs, and compounds.

Stay tuned and check their website for updates on CWCI research.

 


Mar
13

The Affordable Care Act and Work Comp – WCRI’s view

WCRI’s Thursday morning begins with a series of presentations and discussions on the impact of PPACA/Obamacare on workers’ comp.

According to WC Executive Director Rick Victor, “Few pieces of legislation have the potential to affect people both financially and personally as the ACA. ”

(Note – my sense is there’s way too much attribution of normal market changes -positive and negative – to ACA, more on that later)

Rick went on to provide a framework for understanding ACA with specific attention to individual states.  Among the key issues

Will expansion of care lead to:

Shortages of providers who treat injured workers, which may lead to longer disability and higher costs – Victor opined that in states where Medicaid expands shortages will be greater than in non-expansion states. Similarly in states with low health status and/or an older population. As an economist, Victor noted that prices might rise and that will reduce shortages – in this case, payers will pay providers above the fee schedule to get access to care.  There’s a precedent for this in Canada, where providers in Ontario treating work comp patients get paid more than when they treat non-occ patients.  This happens in Massachusetts today as well…

That said, WC ALREADY pays more for specialty care than Medicare or Medicaid or group health in almost all states, so additional payments are likely not necessary. Given a multitude of factors, WCRI predicts the states that will have primary care shortages are:

  • California
  • Florida
  • Louisiana
  • Texas
  • New Mexico
  • Nevada
  • Mississippi

I’d note that most of these are states that – at present – aren’t expanding Medicaid.  If – or more likely when – they decide that Medicaid expansion is a good thing, the predicted provider shortage may get worse.

Healthier employees – The data suggests folks with insurance are healthier than those that are not insured.

Victor doesn’t seem to think ACA will reduce unnecessary care for injured workers. Notably, he didn’t give a time frame for that statement; I firmly believe the work done by PCORI WILL have a dramatic effect on the care that’s delivered to, say, patients with back pain.  That’s going to take time – years, not months, but it will have a big impact.

Lots of discussion of the impact of PPACA on cost shifting – and a wealth of data Rick presented that indicated providers find creative ways to upcode, shift procedure mix, or otherwise find ways to increase revenues in the face of price controls or other regulatory attempts to restrain costs.

My research indicates cost-shifting is a complicated issue.

There’s been a good bit of discussion – some on Mark Walls’ LinkedIn group, on the potential for PPACA to influence claiming behavior.  The net is, I just haven’t seen any credible research that indicates PPACA will lead to more claims.  I’ve discussed this in detail here.

Finally, be careful to NOT attribute anything and everything, good and bad to ACA. A lot of things were occurring before ACA, including provider consolidation, more and higher deductibles, rising costs.

Will ACA accelerate, decelerate or change these trends?  It is impossible to separate out ACA’s effect from that of other factors.

 


Mar
12

WCRI – impact of reform in Illinois

Rebecca Yang analyzed the impact of the 2011 30% fee schedule reduction on prices paid for professional services in IL. Here are the highlights…

  • WC prices paid (not billed, or Fed Schedule) for office visits were 18% lower than group health and 15% below Medicare.
  • Costs for office visits went from 20% above the study state average to 20% below that average after reform.
  • Surgery was a VERY different story; arthroscopic knee surgery costs were 166% higher than group health and 380%+/- above Medicare.
  • Actual prices paid dropped after the reduction, but by 24%, not 30%.  this was likely due to negotiations between the providers and network operators.  In addition, some providers dropped out of networks, eliminating any discount below FS.
  • It appears utilization may have increased, off-setting a third to a half of the impact of price reduction.

Mar
12

WCRI – the effect of WC reform in Texas

Carol Telles spoke briefly on what other states can learn from Texas’ recent reforms – designed to address medical utilization by introducing medical management tools, and reducing utilization. These tools actually added some cost, so the cost:benefit of the reforms have to be considered.

Relative to 14 other states, medical cost per claim over a 15 year period declined from highest among the other states to a position in the bottom third.

A big driver was a large decrease in utilization of non-facility care, which actually dropped by about 30% over the study period.  All other states costs increased, some by 70%.

There were a wide array of changes over a couple different reform periods including broadening the use of UR, implementing health care networks, increasing the prices for medical services, adoption of evidence-based medical guidelines, pre-cert for PT/OT, and a closed formulary for medications.  Most of the effects of these changes weren’t observed until 2011 or 2012, with the formulary’s impact delayed even further.

A few highlights specific to the impact on chiropractic

  • chiro utilization dropped 8.5%; % of claims with chiro dropped 60 percent.
  • the percentage of medical payments for chiro decreased from 10% to 3.5%
  • however, chiros are utilized more in Texas than in any study state except California

Re medical cost containment expenses, costs per claim went up about 40% and have stayed there since the reforms were fully implemented.  These expenses were a third higher than the average study state.

What does this mean for you?

Overall, adding medical management services and their attendant costs appears to be related to reducing medical costs.